Ensysce Biosciences (ENSCW) Other Working Capital Changes (2018 - 2025)
Ensysce Biosciences (ENSCW) reported Other Working Capital Changes of -$779709.0 for Q3 2025, down 140.61% year-over-year from $1.9 million in Q3 2024, and down 280.29% quarter-over-quarter from $432474.0 in Q2 2025.
Ensysce Biosciences (ENSCW) Other Working Capital Changes (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSCW) has 8 years of Other Working Capital Changes data on file, last reported at -$779709.0 in Q3 2025.
- Other Working Capital Changes for Q3 2025 came in at -$779709.0, down 140.61% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.3 million (down 243.62% YoY), and the FY2024 annual result was $251965.0, up 118.1% from the prior year.
- Other Working Capital Changes fell to -$779709.0 in Q3 2025 per ENSCW's latest filing, from $432474.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.9 million in Q3 2024 and troughed at -$1.5 million in Q4 2024.
- A 5-year average of -$103044.6 and a median of -$226810.0 in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1523.7% in 2022 and fell as far as 1035.43% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at $932527.0 in 2021, then sank by 226.24% to -$1.2 million in 2022, then surged by 86.67% to -$156929.0 in 2023, then tumbled by 841.37% to -$1.5 million in 2024, then surged by 47.22% to -$779709.0 in 2025.
- Business Quant data shows ENSCW's Other Working Capital Changes at -$779709.0 in Q3 2025, $432474.0 in Q2 2025, and -$433659.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ensysce Biosciences | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -779,709.00 |
| Sep 30, 2025 | -779,709.00 |
| Jun 30, 2025 | 432,474.00 |
| Jun 30, 2025 | 432,474.00 |
| Mar 31, 2025 | -433,659.00 |
| Mar 31, 2025 | -433,659.00 |
| Dec 31, 2024 | -1.48 Mn |
| Dec 31, 2024 | -1.48 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Sep 30, 2024 | 1.92 Mn |
| Jun 30, 2024 | -277,606.00 |
| Jun 30, 2024 | -277,606.00 |
| Mar 31, 2024 | 86,697.00 |
| Mar 31, 2024 | 86,697.00 |
| Dec 31, 2023 | -156,929.00 |
| Dec 31, 2023 | -156,929.00 |
| Sep 30, 2023 | -765,848.00 |
| Sep 30, 2023 | -765,848.00 |
| Jun 30, 2023 | -226,810.00 |
| Jun 30, 2023 | -226,810.00 |